Cost-Effectiveness in the Surgical Care of Renal Cell Carcinoma

被引：0
|
作者：
不详
机构：
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2018年 / 16卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：177 / 179
页数：3
相关论文
共 50 条
  • [31] STAGING OF RENAL-CELL CARCINOMA - COST-EFFECTIVENESS OF ROUTINE PREOPERATIVE BONE SCANS
    CAMPBELL, RJ
    BROADDUS, SB
    LEADBETTER, GW
    UROLOGY, 1985, 25 (03) : 326 - 329
  • [32] Cost-Effectiveness Analysis and Volume-Based Surgical Care
    Perry, Lauren M.
    Bold, Richard J.
    Hoch, Jeffrey S.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2022, 234 (02) : 249 - 250
  • [33] Cost-effectiveness of Mohs micrographic surgery vs surgical excision for basal cell carcinoma of the face
    Otley, Clark C.
    ARCHIVES OF DERMATOLOGY, 2006, 142 (09) : 1235 - 1235
  • [34] Cost-effectiveness of Mohs micrographic surgery vs surgical excision for basal cell carcinoma of the face
    Essers, BAB
    Dirksen, CD
    Nieman, FHM
    Smeets, NWJ
    Krekels, GAM
    Prins, MH
    Neumann, HAM
    ARCHIVES OF DERMATOLOGY, 2006, 142 (02) : 187 - 194
  • [35] COST-EFFECTIVENESS ANALYSIS OF FIRST-LINE TREATMENT FOR METASTATIC RENAL CELL CARCINOMA IN COLOMBIA
    Nunez, S. M.
    Godoy, J., I
    Cardona, A. F.
    Otero, J. M.
    Lujan, M.
    Lopera, D.
    Carranza, H.
    Spath, A.
    Gis, P. R.
    VALUE IN HEALTH, 2012, 15 (04) : A219 - A219
  • [36] Cost-Effectiveness of Everolimus for Second-Line Treatment of Metastatic Renal Cell Carcinoma in Serbia
    Mihajlovic, Jovan
    Pechlivanoglou, Petros
    Sabo, Ana
    Tomic, Zdenko
    Postma, Maarten J.
    CLINICAL THERAPEUTICS, 2013, 35 (12) : 1909 - 1922
  • [37] COST-EFFECTIVENESS OF TEMSIROLIMUS FOR METASTIC RENAL-CELL CARCINOMA AND POOR PROGNOSIS PATIENTS IN MEXICO
    Arreola-Ornelas, H.
    Rosado-Buzzo, A.
    Garcia-Mollinedo, M.
    Camacho, L.
    Mould-Quevedo, J. F.
    Mucino-Ortega, E.
    Galindo-Suarez, R. M.
    VALUE IN HEALTH, 2011, 14 (03) : A164 - A164
  • [38] COST-EFFECTIVENESS OF PEMBROLIZUMAB AS AN ADJUVANT TREATMENT FOR RENAL CELL CARCINOMA POST-NEPHRECTOMY IN FRANCE
    Apert, M.
    Bensimon, L.
    Marie, L.
    Chau, M.
    Baluni, G.
    Chhabra, N.
    Kundu, A.
    Bhattacharya, R.
    Lai, Y.
    Gross-Goupil, M.
    Ouzaid, I
    VALUE IN HEALTH, 2023, 26 (12) : S183 - S183
  • [39] A COST-EFFECTIVENESS ANALYSIS OF NIVOLUMAB IN COMBINATION WITH IPILIMUMAB FOR THE TREATMENT OF ADVANCED RENAL CELL CARCINOMA IN CANADA
    Lakhdari, K.
    Young, K. C.
    Holdgate, O.
    Doan, J.
    VALUE IN HEALTH, 2018, 21 : S37 - S37
  • [40] Cost-effectiveness of pembrolizumab with axitinib as first-line treatment for advanced renal cell carcinoma
    Bensimon, Arielle G.
    Zhong, Yichen
    Swami, Umang
    Briggs, Allison
    Young, Joshua
    Feng, Yuan
    Song, Yan
    Signorovitch, James
    Adejoro, Oluwakayode
    Chakravarty, Abhiroop
    Chen, Mei
    Perini, Rodolfo F.
    Geynisman, Daniel M.
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (09) : 1507 - 1517
12345